Results

CryoLife Inc.

09/22/2021 | Press release | Distributed by Public on 09/22/2021 14:39

N E W S R E L E A S E (Form 8-K)

N E W S R E L E A S E



FOR IMMEDIATE RELEASE



Contacts:



CryoLife

D. Ashley Lee

Executive Vice President, Chief Financial Officer,

and Chief Operating Officer

Phone: 770-419-3355

Gilmartin Group LLC

Brian Johnston / Lynn Lewis

Phone: 631-807-1986

[email protected]





Anthony Semedo Joins CryoLife Board of Directors





ATLANTA, GA - (September 22, 2021) - CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Semedo to its Board of Directors effective October 1, 2021.



"We are thrilled to welcome Tony, a leader in the aortic space, to our board of directors," commented Pat Mackin, Chairman, President, and Chief Executive Officer. "Tony's demonstrated ability to lead, grow, and integrate diversified global divisions in the medical device space as well as his experience managing robust R&D, quality, and regulatory functions will be instrumental as we advance on our growth trajectory."



Mr. Semedo stated, "I am very excited to join CryoLife as the company continues to grow as a dominant force within the aortic space. I look forward to working with the entire team to support the company's enduring commitment to enabling positive patient outcomes while providing a diversified portfolio to surgeons across the globe."



Mr. Semedo has over 40 years of U.S and international experience in the medical device industry, servingmost recently as Senior Vice President & President of Japan Operations at Medtronic,where he led multiple business units and functions. Through his tenure at Medtronic, Mr. Semedo held several executive management positions including Senior VicePresident & President of the company's Aortic, Peripheral and Venous (APV) Division and Senior Vice President & Presidentof Endovascular Innovations. He previously served as Vice President ofMedtronic'sJapan Cardiovascular Business and as Global Vice President of Vascular Research and Development. Earlier in his career he spent time at Alaris Medical Systems, Eli Lilly & Co., and Abbott Laboratories.Mr. Semedo received his Bachelor of Science in Engineering from the University of Massachusetts.

1655 Roberts Boulevard, NW • Kennesaw, Georgia 30144

(770) 419-3355 Phone • (770) 426-0031 Fax• e-mail: [email protected]

http://www.cryolife.com

About CryoLife, Inc.

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.

Page 2 of 2